← Leaderboards
Maria Lynn Mancini
Beth Israel Deaconess Medical Center
$149,034
Attributed
$149,034
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.2K · FY2008–10$100K$75K$50K$25K$0
'08
'09
'10
Funding mix
By agency
NIH$149,034 · 1
By mechanism
F32$149,034 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Kermit L Carraway$11,333,366
- Huiyan Zeng$2,837,132
- Vassiliki A Boussiotis$19,288,605
- Alex Toker$16,651,718
- Ramesh K Ganju$10,257,043
Others in their field
Top investigators on “9,10-Dimethyl-1,2-Benzanthracene”
- Gail E Sonenshein · Boston University Medical Campus$3,914,675
- Peiqing Sun · Scripps Research Institute$3,252,935
- Joan M Lappe · Creighton University$3,201,792
- Ervin H Epstein · University Of California San Francisco$2,732,941
- David C Seldin · Boston Medical Center$2,604,187
- Daret K St Clair · University Of Kentucky$2,559,543
Research focus
9,10-Dimethyl-1,2-BenzanthraceneIn VitroArtsAffectAnimalsBreedingCancer CellCancer Cell LineBreastCarcinomaBreast Cancer CellCell NucleusCell PhysiologyCell SurvivalDesignDoseEnhancersEpitheliumCancer EtiologyGeneticGrowthInhibitor/AntagonistCell MotilityIn Vivo
Grant awards (3)
Isoform Specific Functions for AKt1 and Akt2 in Breast Cancer Progression$52,154
F32 · FY2010 · CA · contact PI
Isoform Specific Functions for AKt1 and Akt2 in Breast Cancer Progression$50,054
F32 · FY2009 · CA · contact PI
Isoform Specific Functions for AKt1 and Akt2 in Breast Cancer Progression$46,826
F32 · FY2008 · CA · contact PI